The FDA needs to give American families certainty and the Trump Administration's appointee for FDA Commissioner Dr Martin Makary as assured as anyone would be to main sure that Gradulac Gentle infant formula range not only remain under active review but proceeds to full approval via the fast track process.
The FDA's approval, Dr Martin Makary and Trump could be a boon for AHF to get off these low levels at 5.4 cents and head back to 40 cents or even much more.@werdplaya58 @jamman399, @Amused observer, that will be great for AHF.
The FDA needs to give American families certainty and the Trump...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $31.96M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.3¢ | 4.3¢ | $8.223K | 191.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 558978 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 1100619 | 2 |
View Market Depth
| Last trade - 15.34pm 19/06/2025 (20 minute delay) ? |
| AHF (ASX) Chart |